Estia Health Management

Management criteria checks 2/4

Estia Health's CEO is Sean Bilton, appointed in Jul 2022, has a tenure of 1.42 years. total yearly compensation is A$1.31M, comprised of 54.4% salary and 45.6% bonuses, including company stock and options. directly owns 0.43% of the company’s shares, worth A$3.44M. The average tenure of the management team and the board of directors is 1.7 years and 6.4 years respectively.

Key information

Sean Bilton

Chief executive officer

AU$1.3m

Total compensation

CEO salary percentage	54.4%
CEO tenure	1.4yrs
CEO ownership	0.4%
Management average tenure	1.7yrs
Board average tenure	6.4yrs

Recent management updates

Recent updates

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

Feb 25

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Nov 04

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Apr 13

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Mar 08

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Feb 21

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Jan 24

CEO Compensation Analysis

How has Sean Bilton's remuneration changed compared to Estia Health's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2023	AU$1m	AU$709k	-AU$34m
Mar 31 2023	n/a	n/a	-AU$52m
Dec 31 2022	n/a	n/a	-AU$70m
Sep 30 2022	n/a	n/a	-AU$61m
Jun 30 2022	AU$905k	AU$496k	-AU$52m
Mar 31 2022	n/a	n/a	-AU$25m
Dec 31 2021	n/a	n/a	AU$3m
Sep 30 2021	n/a	n/a	AU$4m
Jun 30 2021	AU$640k	AU$478k	AU$6m
Mar 31 2021	n/a	n/a	-AU$66m
Dec 31 2020	n/a	n/a	-AU$137m
Sep 30 2020	n/a	n/a	-AU$127m
Jun 30 2020	AU$551k	AU$479k	-AU$117m
Mar 31 2020	n/a	n/a	-AU$41m
Dec 31 2019	n/a	n/a	AU$35m
Sep 30 2019	n/a	n/a	AU$38m
Jun 30 2019	AU$760k	AU$331k	AU$41m

Compensation vs Market: Sean's total compensation ($USD882.91K) is about average for companies of similar size in the Australian market ($USD845.96K).

Compensation vs Earnings: Sean's compensation has increased whilst the company is unprofitable.

CEO

Sean Bilton

1.4yrs

Tenure

AU$1,305,208

Compensation

Mr. Sean Bilton serves as Chief Executive Officer, Managing Director and Director of Estia Health Limited since July 11 2022. He was Chief Operating Officer at Estia Health Limited since October 23, 2018 u...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Sean Bilton	CEO, MD & Director	1.4yrs	AU$1.31m	0.43% A$ 3.4m
Damian Hiser	Chief Operating Officer	1.4yrs	AU$800.07k	0.044% A$ 354.6k
Anthony Rice	Chief Financial Officer	less than a year	no data	no data
Fiona Caldwell	Chief Information Officer	6.2yrs	no data	no data
Suzy Watson	General Counsel & Chief Privacy Officer	9.2yrs	no data	no data
Cath Gillard	Chief People Officer	1.6yrs	no data	no data
Leanne Laidler	Chief Quality & Risk Officer	4.6yrs	no data	no data
Michael Lockwood	Chief Development & Property Officer	1.7yrs	no data	no data
Leanne Ralph	Company Secretary	4.7yrs	no data	no data

1.7yrs

Average Tenure

Experienced Management: EHE's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Sean Bilton	CEO, MD & Director	1.4yrs	AU$1.31m	0.43% A$ 3.4m
Paul Foster	Independent Non-Executive Director	7.8yrs	AU$145.00k	0.0092% A$ 73.9k
Gary Weiss	Independent Non-Executive Chairman	7.8yrs	AU$280.00k	0.040% A$ 318.2k
Norah Barlow	Independent Non-Executive Director	9.1yrs	AU$125.00k	0.050% A$ 398.7k
Helen Kurincic	Independent Non-Executive Director	6.4yrs	AU$145.00k	0.019% A$ 154.0k
Karen Lee Penrose	Independent Non-Executive Director	5.2yrs	AU$135.00k	0.017% A$ 135.7k
Simon Willcock	Independent Non-executive Director	1.3yrs	AU$100.00k	no data

6.4yrs

Average Tenure

64.5yo

Average Age

Experienced Board: EHE's board of directors are considered experienced (6.4 years average tenure).

Estia Health Management

Management criteria checks 2/4

Key information

Recent management updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Independent Non-Executive Chairman recently bought AU$52k worth of stock

CEO, MD & Director recently bought AU$106k worth of stock

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Recent updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Estia Health Limited (ASX:EHE) entered into a binding agreement to acquire residential aged care homes in Benalla of Royal Freemasons Ltd.

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Bain Capital Reportedly Moves to Sell Craigcare But Abandons Its Pursuit of Estia

Consensus EPS estimates fall by 15%

Price target increased by 12% to AU$2.83

Independent Non-Executive Chairman recently bought AU$52k worth of stock

Consensus EPS estimates fall by 22%, revenue upgraded

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

CEO, MD & Director recently bought AU$106k worth of stock

Consensus forecasts updated

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Consensus estimates of losses per share improve by 51%

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Estia Health Limited Appoints Sean Bilton as Director

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Consensus forecasts updated

Insufficient new directors

Estia Health Limited Announces Management Changes

Estia Health Limited announces resignation of Hon. Warwick L. Smith AO as director, effective 31 March 2022

Consensus forecasts updated

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings: EPS misses analyst expectations

Estia Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Consensus forecasts updated

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.45 loss in FY 2020)

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Price target increased to AU$2.15

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Price target raised to AU$1.94

First half 2021 earnings released: AU$0.02 loss per share (vs AU$0.055 profit in 1H 2020)

Estia Health Limited Not Declare Interim Dividend for the Six Months Ended December 31, 2020

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Estia Health Limited Reaches an Agreement to Settle the Shareholder Class Action Commenced Against It in July 2019

New 90-day high: AU$1.96

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Is Estia Health (ASX:EHE) Using Too Much Debt?

Estia Health Limited to Report Q2, 2021 Results on Feb 23, 2021

Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares?

New 90-day high: AU$1.63

New 90-day low: AU$1.36

New 90-day low: AU$1.37

Non-Executive Director recently bought AU$101k worth of stock

Price target lowered to AU$1.62

Earnings released

Estia Health Limited Determines Not to Declare A Final Dividend for Fiscal Year 2020

Did Estia Health Limited (ASX:EHE) Insiders Buy Up More Shares?

Is There Now An Opportunity In Estia Health Limited (ASX:EHE)?

Estia Health Limited(ASX:EHE) dropped from S&P/ASX 200 Index

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age